Pathophysiology, Genetics & Classification

Question	Answer
1. What is the fundamental molecular etiology and structural classification of the dengue virus?	Dengue virus is a single-stranded, positive-sense RNA virus belonging to the Flaviviridae family and the genus Flavivirus, possessing four distinct serotypes (DENV-1 through DENV-4).
2. Explain the immunological mechanism responsible for severe dengue and Dengue Shock Syndrome during secondary heterotypic infections.	The primary mechanism is Antibody-Dependent Enhancement (ADE), where non-neutralizing cross-reactive antibodies from a prior infection bind to a new serotype, facilitating virus entry into Fc-gamma receptor-bearing cells like macrophages and leading to massive viral replication and cytokine release.
3. Which host genetic polymorphisms are known to influence susceptibility to severe dengue disease?	Polymorphisms in human leukocyte antigen (HLA) alleles, polymorphic variants in the gene encoding the DC-SIGN receptor, and variations in tumor necrosis factor-alpha (TNF-alpha) promoter regions are significantly associated with susceptibility to severe dengue.
4. What is the defining anatomical and pathophysiological hallmark of the critical phase of dengue?	A sudden, transient increase in vascular endothelial permeability leading to massive plasma leakage into serous cavities such as the pleural and peritoneal spaces, characteristically occurring around the time of defervescence.
5. How does the WHO 2009 classification categorize dengue severity compared to the older 1997 classification?	The WHO 2009 classification categorizes dengue into Dengue without warning signs, Dengue with warning signs, and Severe Dengue, replacing the older rigid classification of Dengue Fever, Dengue Hemorrhagic Fever (Grades I-IV), and Dengue Shock Syndrome.
6. What are the specific cellular targets of the dengue virus within the human immune system?	Dendritic cells, monocytes, macrophages, and hepatic Kupffer cells are the primary target cells for viral entry and replication.
7. Which cytokines and inflammatory mediators drive the endothelial hyperpermeability cascade in severe dengue?	A massive cytokine storm is driven by elevated levels of TNF-alpha, interleukin-2 (IL-2), IL-6, IL-8, IL-10, interferon-gamma, and various vascular endothelial growth factors (VEGF).
8. Why does the pulse pressure narrow (≤ 20 mmHg) during compensated dengue shock?	Intense sympathetic vasoconstriction clamps down peripheral systemic vascular resistance, elevating diastolic blood pressure while systolic pressure is temporarily maintained by tachycardia and increased contractility.
9. What anatomical finding on ultrasound is considered an early and highly sensitive sign of plasma leakage?	Gallbladder wall edema, resulting from fluid accumulation in the subserosal layers of the gallbladder wall, is a classic sonographic marker of plasma leakage.
10. Explain the physiological transition from compensated shock to decompensated shock in pediatric dengue.	When plasma volume loss exceeds 25 to 30%, compensatory vasoconstriction and tachycardia fail to maintain cardiac output, leading to decompensation marked by falling systolic blood pressure, poor perfusion, and severe metabolic acidosis.
11. What specific pathophysiological changes occur in the liver during severe dengue infection?	Direct viral cytopathic injury and immune-mediated apoptosis lead to hepatocyte necrosis, elevated transaminases, centrilobular congestion, and sometimes acute liver failure.
12. What is the pathogenesis of thrombocytopenia in acute dengue infection?	Thrombocytopenia results from a combination of bone marrow suppression by the virus, peripheral destruction, and immune-mediated clearance of platelets.
13. Why is the clinical onset of plasma leakage temporally linked with the defervescence phase?	Defervescence coincides with a peak in the release of vasoactive cytokines and inflammatory mediators from infected immune cells, triggering sudden endothelial permeability.
14. What is the role of the non-structural protein 1 (NS1) antigen in dengue pathogenesis?	NS1 is secreted into the bloodstream in high concentrations, directly binds to human endothelial cells, and disrupts the endothelial glycocalyx layer, thereby promoting vascular leak.
15. How does secondary infection with a heterotypic dengue serotype alter the host immune response?	It triggers original antigenic sin and ADE, wherein low-affinity memory T-cells and cross-reactive antibodies fail to neutralize the virus while enhancing viral uptake into host mononuclear cells.
16. VIVA TRAP: 18. VIVA TRAP: Does the presence of high-titer neutralizing antibodies fully protect a child against subsequent severe dengue?	NO. Sub-neutralizing levels of cross-reactive antibodies from a previous infection actually exacerbate disease severity through Antibody-Dependent Enhancement (ADE) upon exposure to a different serotype.
17. What are the key pathophysiological mechanisms responsible for bleeding manifestations in severe dengue?	Bleeding is multifactorial, caused by severe thrombocytopenia, consumptive coagulopathy due to Disseminated Intravascular Coagulation (DIC), endothelial dysfunction, and impaired platelet function.

Clinical History & Bedside Evaluation

Question	Answer
1. How does the chronological progression of symptoms typically shift from the febrile phase to the critical phase around Day 4 to Day 5?	The child initially presents with high continuous fever, myalgias, and facial flushing for 3 to 4 days, followed abruptly by defervescence (normalization of temperature) coinciding with the onset of plasma leakage and shock.
2. What specific presenting gastrointestinal symptoms in the history strongly predict impending severe capillary leak and shock?	Severe, continuous abdominal pain or tenderness and persistent vomiting (three or more episodes in 24 hours) are critical red-flag symptoms preceding shock.
3. Why is a detailed dietary and fluid intake recall crucial during the bedside evaluation of a child with suspected dengue?	It helps assess total oral fluid tolerance, identify children who are unable to maintain adequate hydration due to persistent vomiting, and guide baseline fluid deficit calculations.
4. What specific aspects of the perinatal and developmental history should be specifically inquired about when evaluating an infant with suspected severe dengue?	History of maternal dengue infection during the third trimester, gestational age, and birth weight must be noted, as maternal antibody transfer plays a major pathogenic role in infant severe dengue.
5. How does the family pedigree and household micro-epidemiology assist in establishing an early bedside diagnosis of dengue?	A history of similar acute febrile illnesses, diagnosed dengue, or active mosquito breeding sites among siblings or household contacts significantly raises the pre-test probability of dengue.
6. What historical red flags help differentiate acute dengue shock from septic shock or acute abdomen during bedside evaluation?	A history of preceding high fever with retro-orbital pain, bone-breaking myalgias, and a distinct temporal drop in fever right before shock onset point toward dengue rather than surgical abdomen or sepsis.
7. Which predisposing host risk factors in the clinical history increase a child's susceptibility to developing Dengue Shock Syndrome?	Secondary heterotypic infection (prior exposure to a different dengue serotype), female gender, underlying atopy, and chronic medical conditions like bronchial asthma or sickle cell disease.
8. Why is a history of recent travel or residential locality (urban vs. rural) essential when evaluating a child with undifferentiated fever?	Dengue is primarily an urban and peri-urban disease transmitted by Aedes aegypti; knowing the child's exact residence or recent travel to endemic zones confirms epidemiological risk.
9. What specific bleeding symptoms in the clinical history indicate mucosal involvement and warrant urgent warning sign recognition?	Spontaneous epistaxis, gum bleeding, hematemesis, melena, heavy menstrual bleeding in adolescent females, or petechiae observed by parents.
10. How does central nervous system involvement manifest historically and clinically during the critical phase of dengue?	Parents may report extreme lethargy, restlessness, irritability, or confusion, which can stem directly from cerebral hypoperfusion due to shock or occasionally direct neurotropism.
11. What physical sign on bedside inspection of the skin during the early febrile phase is characteristic of acute dengue?	A transient macular flush or facial erythema over the face, neck, and chest, which blanches upon pressure and can mimic scarlet fever or measles.
12. Why must a clinician inquire about the exact day of fever onset rather than just duration during the initial clinical evaluation?	Because the management strategy and risk of catastrophic complications change completely depending on whether the child is in the febrile, critical (Days 4–6), or recovery phase.
13. What bedside evaluation technique is used to assess vascular capillary fragility, and what is its clinical significance?	The Tourniquet Test (Rumpel-Leede test); inflating a sphygmomanometer cuff to the mean systolic-diastolic pressure for 5 minutes and counting petechiae helps screen for capillary fragility, though a negative test does not rule out dengue.
14. What historical feature distinguishes the rash of the critical/shock phase from the rash seen in the recovery phase of dengue?	The critical phase features petechiae associated with bleeding, whereas the recovery phase characteristically shows the "isles of white in a sea of red" (convalescent macular rash with spared areas).
15. VIVA TRAP: 18. VIVA TRAP: Is hepatomegaly detected during the bedside evaluation of a dengue patient always a sign of acute liver failure?	NO. Hepatomegaly (> 2 cm below the right costal margin) is a standard WHO warning sign reflecting acute hepatic congestion, viral replication, or mild hepatitis, not necessarily fulminant hepatic failure.
16. What specific signs of fluid accumulation should a clinician actively search for during routine physical examination in the critical phase?	Examination must specifically check for decreased breath sounds and dullness at lung bases (pleural effusion), shifting dullness or fluid thrill (ascites), and tender hepatomegaly.
17. How does the presence of underlying malnutrition or obesity impact the clinical presentation and fluid management assessment in severe dengue?	Malnutrition alters baseline vascular compliance and complicates fluid calculations, while obesity masks clinical signs of dehydration and makes the accurate assessment of peripheral pulses and perfusion challenging.

Physical Examination & Bedside Signs

Question	Answer
1. What is the standard bedside method for anthropometric weight estimation in an emergency pediatric dengue resuscitation when the child is too unstable to weigh?	1. Use the APLS length-based tape or formula (Age in years + 4) × 2. 2. Alternatively, use standard age-based weight estimation charts for emergency drug and fluid calculations, ensuring baseline pre-illness weight is obtained from parents once stabilized to prevent fluid overload.
2. How do you correctly elicit and interpret the Rumpel-Leede tourniquet test at the bedside for capillary fragility?	1. Inflate a sphygmomanometer cuff on the child's arm to a point midway between systolic and diastolic blood pressure (or mean arterial pressure) for exactly 5 minutes. 2. Release the cuff, wait 2 minutes, and count petechiae within a 2.5 cm square (1 inch square) on the forearm; a count ≥ 20 petechiae is positive, indicating capillary fragility.
3. How do you systematically grade and document peripheral perfusion during bedside inspection in suspected compensated dengue shock?	1. Assess capillary refill time (CRT) by firm digital pressure on the nail bed or sternum for 5 seconds; a CRT > 3 seconds indicates impaired peripheral perfusion. 2. Inspect for skin color (pale, mottled, cyanotic) and temperature gradient (cold clammy extremities extending above the wrists and ankles).
4. What is the specific bedside technique and anatomical landmark used to measure hepatomegaly in a child with suspected dengue?	1. Palpate gently starting from the right iliac fossa upwards along the mid-clavicular line toward the right costal margin. 2. Measure the liver span in centimeters below the right costal margin and assess its consistency and tenderness, noting that a liver edge > 2 cm is a WHO warning sign.
5. What auscultatory signs over the chest indicate critical plasma leakage into the serous cavities during physical examination?	1. Diminished or absent breath sounds with stony dullness on percussion at the right lung base (or bilateral bases). 2. These findings signify a right-sided or bilateral pleural effusion secondary to capillary leak during the critical phase.
6. How do you perform a precise blood pressure measurement to detect narrowing pulse pressure in a child with compensated shock?	1. Use an appropriately sized pediatric cuff covering two-thirds of the upper arm. 2. Accurately auscultate or use an automated monitor to determine that the difference between systolic and diastolic pressures is ≤ 20 mmHg (e.g., 90/74 mmHg).
7. What specific signs on cardiovascular auscultation suggest myocardial involvement or fluid overload during severe dengue management?	1. Presence of a gallop rhythm (S3 or S4) indicating myocardial dysfunction or myocarditis. 2. Muffled heart sounds due to pericardial effusion or bilateral basal crepitations and wheezes indicating impending pulmonary edema from over-resuscitation.
8. How is abdominal tenderness evaluated and graded during the physical examination of a child entering the critical phase of dengue?	1. Perform gentle, systematic superficial and deep palpation across all four quadrants, specifically focusing on the epigastrium and right upper quadrant. 2. Severe, continuous tenderness in these zones indicates acute hepatic stretching, pancreatitis, or serosal inflammation, serving as a primary WHO warning sign.
9. What neurological sign on mental status examination distinguishes early warning lethargy from normal sleep in a febrile child with dengue?	1. Assessment using the AVPU (Alert, Verbal, Pain, Unresponsive) scale or Glasgow Coma Scale (GCS). 2. Lethargy manifested as apathy, delayed response to verbal commands, or unprovoked irritability that is out of proportion to fever severity indicates cerebral hypoperfusion or encephalopathy.
10. How do you clinically examine for subtle third-space fluid accumulation (ascites) in a pediatric dengue patient at the bedside?	1. Inspect the abdomen for distension and shifting fullness. 2. Elicit a fluid thrill or demonstrable shifting dullness on percussion, keeping in mind that dependent edema in the sacral region or periorbital puffiness may also signify capillary leak.
11. What bedside inspection sign in the eyes points toward acute dengue fever during the early clinical evaluation?	1. Conjunctival suffusion and mild periorbital erythema. 2. This reflects acute viral-induced mucosal vascular congestion distinct from bacterial conjunctivitis or hemorrhagic manifestations.
12. How do you assess peripheral pulse volume and character to differentiate compensated from uncompensated dengue shock?	1. Palpate peripheral pulses (radial, dorsalis pedis, posterior tibial) alongside central pulses (carotid, femoral). 2. Compensated shock presents with a weak, rapid, thready peripheral pulse with preserved central pulses, whereas decompensated shock exhibits absent peripheral pulses and feeble or unrecordable central pulses.
13. How is skin turgor and mucosal hydration status evaluated in a child with dengue presenting with persistent vomiting and fluid loss?	1. Assess skin pinch over the abdomen (evaluating recoil time) and inspect the moistness of the buccal mucosa and tongue. 2. Note that dehydration from vomiting can coexist with third-space plasma leakage, making physical assessment of intravascular versus interstitial fluid status extremely challenging.
14. What bedside technique is used to evaluate postural vital sign changes (orthostatic hypotension) in older children suspected of early plasma leakage?	1. Measure heart rate and blood pressure in the supine position and then after 2 to 3 minutes of standing. 2. An orthostatic increase in heart rate of ≥ 20 bpm or a drop in systolic blood pressure of ≥ 10 mmHg indicates significant intravascular volume depletion.
15. VIVA TRAP: 18. VIVA TRAP: Can the absence of hepatomegaly reliably rule out the diagnosis of severe dengue or the critical plasma leakage phase?	1. NO. 2. Hepatomegaly is a prominent warning sign when present due to hepatic congestion and edema, but its absence does not exclude severe dengue, compensated shock, or critical plasma leakage.
16. What specific auscultatory and percussion findings over the lower back and flanks help detect hidden fluid collections in children with dengue shock?	1. Percussion of shifting dullness in the flanks and auscultation of diminished breath sounds at the lung bases. 2. These findings confirm serous cavity effusions (pleural effusion and ascites) reflecting generalized endothelial hyperpermeability.
17. How do you clinically evaluate capillary refill time in a neonate or infant presenting with atypical severe dengue shock?	1. Press firmly on the central forehead, sternum, or plantar surface of the foot for 5 seconds. 2. A refill time exceeding 3 seconds indicates compromised peripheral perfusion and early circulatory compromise requiring immediate fluid resuscitation.

Diagnostic Criteria & Investigations

Question	Answer
1. What is the gold standard serological test for diagnosing acute dengue infection within the first 5 days of fever onset?	1. Non-structural protein 1 (NS1) antigen ELISA or rapid immunochromatographic test is the gold standard in the early febrile phase. 2. NS1 antigen remains detectable in serum from Day 1 up to Day 7 of illness, regardless of primary or secondary infection status.
2. What specific antibody isotype profile on serology confirms a secondary dengue infection versus a primary dengue infection?	1. Secondary dengue is characterized by an early and markedly elevated IgG response alongside IgM, often with a high IgG-to-IgM ratio even in the acute phase. 2. Primary dengue shows a delayed IgM appearance (usually after Day 5) with low or absent IgG during the acute phase.
3. At what specific threshold does thrombocytopenia become a defining laboratory criterion for severe dengue or warning sign classification?	1. A rapid drop in platelet count to below 100,000 per microliter (or a progressive, precipitous downward trend on serial counts) serves as a key warning sign. 2. Severe bleeding usually correlates with counts dropping below 20,000 per microliter, though functionality matters more than absolute numbers.
4. What absolute hematocrit cutoff and dynamic change signify significant plasma leakage in a suspected severe dengue case?	1. A rise in hematocrit equal to or greater than 20% above the baseline age-matched population average indicates significant hemoconcentration and plasma leakage. 2. Conversely, a sudden drop in hematocrit without volume resuscitation signifies occult internal hemorrhage.
5. What is the reference standard virological method for confirming dengue virus serotype and viral load in research or outbreak settings?	1. Real-time Reverse Transcription Polymerase Chain Reaction (RT-PCR) is the reference standard. 2. It identifies the specific dengue serotype (DENV-1 to DENV-4) and quantifies viral load, which is highest during the early febrile phase.
6. What biochemical blood gas abnormality is the earliest and most sensitive indicator of uncompensated tissue hypoperfusion in Dengue Shock Syndrome?	1. Metabolic acidosis characterized by an elevated blood lactate level (greater than 2.0 mmol/L) and a widened anion gap. 2. It reflects anaerobic cellular metabolism resulting from prolonged microcirculatory hypoperfusion and shock.
7. How do liver function tests characteristically derange in severe dengue during the critical phase?	1. Serum transaminases (AST and ALT) invariably rise, with AST characteristically higher than ALT due to direct viral myositis and hepatocellular injury. 2. Levels can exceed 500 IU/L, and severe elevations correlating with coagulopathy indicate severe hepatic involvement.
8. What bedside or laboratory coagulation profile abnormalities are typically observed in children with severe dengue hemorrhagic manifestations?	1. Prolonged Prothrombin Time (PT) and Activated Partial Thromboplastin Time (aPTT) reflecting consumption coagulopathy. 2. Hypofibrinogenemia and elevated D-dimer levels point toward secondary Disseminated Intravascular Coagulation (DIC) in profound shock.
9. What specific ultrasonographic finding in the abdomen is considered pathognomonic for plasma leakage during the critical phase of dengue?	1. Thickening of the gallbladder wall (greater than 3 to 4 mm in children) due to subserosal edema resulting from capillary plasma leakage. 2. Ascites and bilateral or right-sided pleural effusion are also readily visualized on bedside point-of-care ultrasound (POCUS).
10. What diagnostic imaging feature on a chest radiograph confirms critical plasma leakage in a deteriorating dengue patient?	1. Blunting of the right costophrenic angle or presence of right-sided pleural effusion, which frequently precedes bilateral effusions. 2. Cardiomegaly or pulmonary edema may also be seen if fluid overload complicates aggressive resuscitation.
11. What renal biomarker cutoffs indicate acute kidney injury (AKI) secondary to prolonged renal hypoperfusion in Dengue Shock Syndrome?	1. A rise in serum creatinine to greater than 1.5 times baseline or oliguria defined as urine output less than 0.5 mL/kg/hour for 6 consecutive hours. 2. AKI in dengue is predominantly prerenal secondary to plasma leakage, but can progress to acute tubular necrosis if shock is refractory.
12. What specific electrolyte disturbance is classically associated with severe dengue and requires frequent monitoring during fluid resuscitation?	1. Hyponatremia (serum sodium less than 130 mEq/L) is common due to syndrome of inappropriate antidiuretic hormone secretion (SIADH) and hypotonic fluid administration. 2. Hypokalemia and hypocalcemia may also occur and need aggressive correction to prevent myocardial dysfunction.
13. How do serum cardiac biomarkers such as Troponin-I and NT-proBNP behave in children with complicated Dengue Shock Syndrome?	1. Troponin-I and NT-proBNP levels are frequently elevated, indicating direct viral myocarditis or myocardial stunning secondary to severe shock and hypoxia. 2. These biomarkers help differentiate pure hypovolemic/leaky shock from cardiogenic shock.
14. What laboratory clotting parameter should be evaluated before performing any invasive procedure or central line placement in a dengue patient?	1. A complete coagulation profile including PT, INR, aPTT, and a fresh platelet count. 2. Invasive procedures should be deferred or corrected with fresh frozen plasma if significant coagulopathy and severe thrombocytopenia coexist.
15. What diagnostic utility do paired acute and convalescent serological titers hold in routine pediatric clinical management of dengue?	1. Paired titers demonstrating a fourfold rise in IgG between acute and convalescent phases confirm dengue retrospectively. 2. They have limited utility in acute emergency management because results are delayed, but are vital for epidemiological surveillance.
16. What hematological index on a complete blood count differentiates dengue fever from acute bacterial sepsis in endemic settings?	1. Dengue characteristically presents with profound leukopenia (total leukocyte count less than 4,000 cells/uL) with relative atypical lymphocytosis, unlike bacterial sepsis which typically shows leukocytosis and a left shift. 2. The presence of toxic granules strongly favors bacterial infection over dengue.
17. What specific cutoff of serum albumin assists in diagnosing severe capillary plasma leakage syndrome in dengue?	1. Hypoalbuminemia (serum albumin less than 3.0 g/dL) resulting from transudation of albumin-rich plasma across damaged endothelial barriers into the interstitial and serous spaces. 2. It serves as an objective laboratory confirmation of generalized capillary leak.
18. VIVA TRAP: 18. VIVA TRAP: Can a negative dengue NS1 antigen test and negative IgM ELISA on Day 3 of fever completely rule out acute dengue infection?	1. NEVER. 2. NS1 antigen sensitivity drops after Day 5, and primary IgM antibodies typically do not appear until Day 5 to 6 of illness; hence, early negative serology does not rule out dengue, and clinical judgment with repeat testing is mandatory.
19. What point-of-care laboratory investigation is mandatory prior to initiating any fluid bolus in a child presenting with shock features?	1. Immediate point-of-care hematocrit and bedside blood glucose estimation. 2. Hematocrit guides whether the shock is primarily due to hemoconcentrating plasma leak or hemorrhage, while hypoglycemia must be immediately ruled out in distressed pediatric patients.
20. What specific abnormality on an electrocardiogram (ECG) warns of myocardial compromise or electrolyte toxicity in a child with severe dengue?	1. Sinus bradycardia during convalescence is physiological, but acute ST-T wave changes, prolonged QTc interval, low voltage complexes, or conduction blocks indicate dengue myocarditis. 2. Arrhythmias mandate continuous cardiac telemetry and electrolyte correction.

Evidence-Based Management & Pharmacotherapy

Question	Answer
1. What is the initial fluid resuscitation rate and type for an 8-year-old child presenting with Compensated Dengue Shock Syndrome (tachycardia, cold peripheries, pulse pressure ≤ 20 mmHg)?	1. Infuse isotonic crystalloids (0.9% Normal Saline or Ringer's Lactate) at 5 to 10 mL/kg/hour over 1 hour. 2. Reassess clinical perfusion and hematocrit before stepping down the fluid rate sequentially over the next 4 to 6 hours.
2. When should a clinician switch from crystalloids to colloids in refractory Dengue Shock Syndrome, and what agents are recommended?	1. Switch to colloids (6% Hydroxyethyl Starch, Dextran 40, or 5% Albumin) when shock persists despite 40 to 60 mL/kg of crystalloid boluses and the hematocrit remains high (>45–50%). 2. Administer colloids at 10 to 20 mL/kg over 30 to 60 minutes.
3. What is the specific therapeutic intervention when a child in dengue shock shows sudden clinical deterioration accompanied by a sharply dropping hematocrit (e.g., from 48% to 32%)?	1. This indicates occult internal hemorrhage (gastrointestinal bleeding). 2. Immediately stop aggressive crystalloid/colloid infusions and transfuse Fresh Whole Blood at 20 mL/kg or Packed Red Cells at 10 mL/kg.
4. VIVA TRAP: 5. VIVA TRAP: Should prophylactic platelet concentrates be transfused to a stable child with severe dengue whose platelet count drops below 20,000/µL without active bleeding?	NO. Prophylactic platelet transfusions are strictly contraindicated because they do not reduce bleeding risk, prolong hospital stay, and significantly increase the incidence of fluid overload and TRALI.
5. Under what specific clinical circumstances are platelet transfusions or blood component therapy explicitly indicated in severe dengue?	1. Platelet transfusions are indicated only in the presence of severe, life-threatening bleeding accompanied by profound thrombocytopenia. 2. Fresh Frozen Plasma (FFP) or cryoprecipitate is indicated only if there is coexisting disseminated intravascular coagulation (DIC) with active microvascular bleeding.
6. How do you step down maintenance and resuscitation IV fluids as the child enters the 24 to 48 hour recovery (convalescent) phase?	1. Progressively reduce the IV fluid rate every 2 to 4 hours (e.g., 5–7 mL/kg/hr → 3–5 mL/kg/hr → 2–3 mL/kg/hr). 2. Discontinue IV fluids entirely once plasma leakage ceases, vitals normalize, and oral intake is fully established to prevent hypervolemic pulmonary edema.
7. What is the mechanism of action and primary risk associated with the administration of Dextran 40 as a colloid in refractory dengue shock?	1. Dextran 40 acts as a macromolecular plasma volume expander that exerts high oncotic pressure to retain fluid intravascularly. 2. Its major risks include severe anaphylactoid reactions and interference with cross-matching and coagulation (increasing bleeding diathesis).
8. Why are loop diuretics (such as Furosemide) contraindicated during the active plasma leakage (critical) phase of Dengue Shock Syndrome?	1. Diuretics deplete the intravascular volume further because fluid is sequestered in the interstitial space (third-space loss). 2. Giving furosemide during shock worsens effective circulating volume depletion and deepens hypovolemic shock.
9. What is the physiological rationale for avoiding hypotonic intravenous fluids (such as 0.225% saline or 0.45% saline) in children with dengue shock?	1. Hypotonic fluids rapidly shift out of the intravascular space into the interstitial and intracellular spaces, exacerbating third-space plasma leakage. 2. They also carry a severe risk of inducing acute hyponatremia and cerebral edema.
10. How should persistent vomiting in the critical phase of dengue be managed pharmacologically to ensure adequate oral hydration tolerance?	1. Administer weight-based antiemetics such as intravenous Ondansetron (0.15 mg/kg/dose, max 4 mg). 2. Avoid oral antiemetics until vomiting is controlled and parenteral hydration is optimized to prevent aspiration and worsening dehydration.
11. What is the role of antipyretic therapy in managing high fever during the febrile phase of dengue, and which drug must be strictly avoided?	1. Use Paracetamol at 10 to 15 mg/kg/dose orally or IV every 4 to 6 hours for high discomfort-associated fever. 2. NEVER use Aspirin or NSAIDs (Ibuprofen, Mefenamic acid) because they inhibit platelet function, aggravate gastritis, and precipitate severe hemorrhage or Reye syndrome.
12. What specific clinical signs mandate immediate cessation of ongoing IV fluid boluses during dengue resuscitation to prevent iatrogenic complications?	1. Appearance of respiratory distress, tachypnea, basal crepitations, gallop rhythm, hepatomegaly enlargement, or clinical signs of pulmonary edema. 2. If these occur, stop IV fluids immediately, administer supplemental oxygen, and consider an emergency rescue dose of IV Furosemide (1 mg/kg) if pulmonary edema is confirmed.
13. What are the specific pharmacological management steps when a child with dengue develops refractory shock complicated by myocardial dysfunction and low ejection fraction?	1. Inotropic support with continuous infusion of Dobutamine (5 to 20 mcg/kg/min) or Dopamine is indicated. 2. Fluids must be restricted and titrated strictly using point-of-care ultrasound (POCUS) / echocardiography to avoid worsening heart failure.
14. How is acute fluid overload managed pharmacologically in a recovering dengue patient who received excessive IV fluids during the plasma leakage phase?	1. Stop all non-essential IV fluids immediately. 2. Administer IV Furosemide at 1 mg/kg to induce prompt diuresis, and provide supplemental low-flow oxygen if SpO2 drops below 94%.
15. What is the recommended dosing regimen for empirical broad-spectrum antibiotic coverage if bacterial sepsis cannot be clinically ruled out from severe dengue shock?	1. Administer weight-appropriate IV third-generation cephalosporins (e.g., Ceftriaxone 75–100 mg/kg/day or Cefotaxime 150 mg/kg/day). 2. De-escalate or discontinue antibiotics immediately once blood cultures return negative and viral etiology is confirmed.
16. VIVA TRAP: 18. VIVA TRAP: Can corticosteroids (such as intravenous Methylprednisolone or Dexamethasone) be routinely administered to reduce mortality or shorten the critical phase of severe dengue?	NO. Multiple large-scale randomized controlled trials have conclusively demonstrated that systemic corticosteroids do not alter the natural course of severe dengue, reduce mortality, or shorten shock duration, and they increase risks of secondary infections and hyperglycemia.
17. What baseline and serial laboratory parameters must be monitored hourly or bi-hourly to guide titration of fluid therapy in Dengue Shock Syndrome?	1. Serial Hematocrit (Hct) levels every 2 to 4 hours. 2. Urine output monitoring via urinary catheterization (target ≥ 1 mL/kg/hour), alongside continuous heart rate, blood pressure, and pulse oximetry monitoring.
18. What is the recommended pharmacological approach for managing severe metabolic acidosis (pH < 7.15, base excess < -10) refractory to initial fluid resuscitation in Dengue Shock Syndrome?	1. Primary management of metabolic acidosis is rapid restoration of tissue perfusion using appropriate crystalloid or colloid boluses and inotropic support. 2. Sodium bicarbonate infusion is reserved strictly for severe refractory acidemia (pH < 7.10) and must be calculated precisely to avoid paradoxical intracellular acidosis and hypernatremia.

High-Yield VIVA TRAPs & Examiner Pitfalls

Question	Answer
1. VIVA TRAP: Should you give a rapid 20 mL/kg normal saline bolus to a child with compensated dengue shock who has a pulse pressure of 18 mmHg and normal blood pressure?	NEVER. Give 5–10 mL/kg of isotonic crystalloids over 1 hour; a rapid 20 mL/kg bolus in compensated shock risks precipitating acute pulmonary edema due to ongoing capillary leak.
2. VIVA TRAP: Can you use Hydroxyethyl Starch (HES) as the primary first-line fluid resuscitation agent for all children presenting with dengue shock?	NEVER. HES is associated with coagulopathy, renal failure, and increased mortality; colloids like HES or Dextran are reserved strictly for refractory shock where hematocrit remains high despite crystalloid boluses.
3. VIVA TRAP: Is routine prophylactic administration of fresh frozen plasma (FFP) indicated to correct prolonged PT/aPTT in a non-bleeding child with severe dengue?	NO. Coagulopathy and thrombocytopenia in dengue are transient and self-limiting; prophylactic FFP does not prevent bleeding and significantly worsens fluid overload.
4. VIVA TRAP: Can you administer intramuscular injections or deep IM antipyretics to a child with severe dengue who has a platelet count of 15,000/µL?	NEVER. Intramuscular injections are strictly contraindicated due to the high risk of severe localized intramuscular hematoma formation and uncontrolled bleeding.
5. VIVA TRAP: Should you administer aspirin instead of paracetamol for high fever control during the initial febrile phase of suspected dengue?	NEVER. Aspirin, ibuprofen, and other NSAIDs are strictly contraindicated because they inhibit platelet aggregation, induce severe gastritis, and precipitate life-threatening hemorrhage or Reye syndrome.
6. VIVA TRAP: Can you safely use hypotonic maintenance intravenous fluids (such as 0.18% Saline in 5% Dextrose) for a child admitted with dengue warning signs?	NEVER. Hypotonic fluids rapidly extravasate into the interstitial space due to increased capillary permeability, worsening hyponatremia, cerebral edema, and third-space fluid accumulation.
7. VIVA TRAP: Is it appropriate to administer a potent loop diuretic like furosemide during the critical leakage phase to treat moderate pleural effusion and ascites?	NEVER. Diuretics deplete intravascular volume during ongoing plasma leakage, converting compensated shock into catastrophic decompensated shock and severe multi-organ hypoperfusion.
8. VIVA TRAP: Can you administer prophylactic broad-spectrum intravenous antibiotics (such as meropenem and vancomycin) to every child admitted with severe dengue to prevent secondary bacterial infection?	NONE. Routine prophylactic antibiotics are not recommended unless there is clear clinical or laboratory evidence of secondary bacterial sepsis or documented co-infection.
9. VIVA TRAP: Should you perform an emergency diagnostic lumbar puncture on a lethargic child with dengue who has a platelet count of 22,000/µL and suspected meningoencephalitis?	NEVER. Lumbar puncture is absolutely contraindicated in severe thrombocytopenia and bleeding diathesis until platelets are adequately corrected or alternative safer neuroimaging is evaluated.
10. VIVA TRAP: Can you continue maintenance IV fluids at high rates into the convalescent phase once the fever subsides and the child's appetite returns?	NO. Continuing high-rate IV fluids into the recovery phase, when extravasated plasma reabsorbs back into the vascular space, will inevitably precipitate hypervolemic pulmonary edema and heart failure.
11. VIVA TRAP: Is routine administration of intravenous sodium bicarbonate indicated for mild-to-moderate metabolic acidosis (pH 7.25) during initial dengue shock resuscitation?	NO. Sodium bicarbonate is not recommended for mild-to-moderate metabolic acidosis; restoring adequate tissue perfusion and effective circulating volume with isotonic crystalloids is the definitive treatment.
12. VIVA TRAP: Can you discharge a child with dengue on Day 6 of illness simply because their platelet count has started rising, ignoring persistent lethargy and severe abdominal pain?	NEVER. Discharge criteria require a minimum of 48 hours afebrile without antipyretics, stable hematocrit without IV fluids, resolving clinical warning signs, and good appetite, regardless of platelet count.
13. VIVA TRAP: Should you administer subcutaneous low-molecular-weight heparin (LMWH) for deep vein thrombosis prophylaxis in a teenager with severe dengue and hemoconcentration?	NEVER. Anticoagulants and antiplatelet agents are strictly contraindicated in severe dengue due to the high risk of catastrophic gastrointestinal hemorrhage and bleeding complications.
14. VIVA TRAP: Can you use enteral nasogastric tube feeding with high-osmolar formulas during active gastrointestinal bleeding or severe abdominal pain in dengue shock?	NO. Enteral feeding should be withheld during active gastrointestinal bleeding or severe abdominal pain with ileus, keeping the gut rested until hemodynamic stability and pain resolution are achieved.
15. VIVA TRAP: Can you insert a central venous catheter via the internal jugular or subclavian route in a child with uncorrected severe thrombocytopenia and profound shock?	NEVER. Central venous access via non-compressible sites is contraindicated in severe coagulopathy; peripheral intravenous access or ultrasound-guided peripheral lines should be prioritized.
16. VIVA TRAP: Should you administer a high-dose stat IV fluid bolus of 20 mL/kg every hour for 4 consecutive hours if a child's hematocrit remains elevated at 52%?	NEVER. Persistent high hematocrit with signs of fluid overload or hepatomegaly indicates ongoing capillary leak and fluid sequestration, not under-resuscitation; continuing large boluses will cause fatal pulmonary edema.
17. VIVA TRAP: Can you rely solely on automated non-invasive blood pressure cuffs without palpating peripheral pulses or checking pulse pressure to assess shock severity in dengue?	NO. Automated cuffs can misread or overestimate blood pressure during intense peripheral vasoconstriction; manual blood pressure measurement and palpation of pulse volume and narrowing pulse pressure are mandatory.